Rafe Shellooe

4.7k citations
9 papers · 3.8k · 3 hit papers · h-index 9

Impact in

Papers in

Rafe Shellooe

9 papers receiving 3.7k citations

Rafe Shellooe's Hit Papers

Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor 2015 · 467 citations
4670+6+12Years since publication50010001.5k

Peers

Rafe Shellooe
Comparison fields: 5 of 99
  • Oncology 1.3k
  • Computational Theory and Mathematics 694
  • Molecular Biology 2.7k
  • Pathology and Forensic Medicine 435
  • Hematology 231
Replace Ben Powell with:
Ben Powell United States
Adhirai Marimuthu United States
Mary J. C. Ludlam Australia
Brian Higgins United States
Angela Hayes United Kingdom
James Y. Tsai United States
Dan Niculescu‐Duvaz United Kingdom
Baole Wang United States
Valerie M. Good United Kingdom
Chris M. Jones Italy
Rafe Shellooe relative to Ben Powell United States Ben Powell's profile →
Citations per field
00.5×1.5×
Ben Powell · 1×
Citations per year

Countries citing papers authored by Rafe Shellooe

Since Specialization
Citations

This map shows the geographic impact of Rafe Shellooe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafe Shellooe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafe Shellooe more than expected).

Fields of papers citing papers by Rafe Shellooe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafe Shellooe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafe Shellooe. The network helps show where Rafe Shellooe may publish in the future.

No co-authors to show.

All Works

9 of 9 papers shown
#Work
1
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Hit paper breakdown →
20101518
2
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
Hit paper breakdown →
20081128
3
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor
Hit paper breakdown →
2015467
4 2015315
5 2015155
6 2018112
7 201384
8 202136
9 201832

About Rafe Shellooe

Rafe Shellooe is a scholar working on Pathology and Forensic Medicine, Oncology, Immunology, Molecular Biology and Gastroenterology, having authored 9 papers that have together received 3.8k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (4 papers), Cancer Mechanisms and Therapy (3 papers), Mast cells and histamine (1 paper), Veterinary Oncology Research (1 paper), CAR-T cell therapy research (1 paper), Immunotherapy and Immune Responses (1 paper), Gastrointestinal Tumor Research and Treatment (1 paper) and Synthesis and biological activity (1 paper). The work is most often cited by research in Oncology (1.3k citations), Computational Theory and Mathematics (694 citations), Molecular Biology (2.7k citations), Pathology and Forensic Medicine (435 citations) and Hematology (231 citations). Rafe Shellooe has collaborated with scholars based in United States. Their work appears in journals such as Nature, Cancer Discovery, Proceedings of the National Academy of Sciences, New England Journal of Medicine and JAMA Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact